{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:17:16Z","timestamp":1787509036507,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001001","name":"Dementia Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008710","name":"Dementia Australia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jamda.2024.105237","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:27:26Z","timestamp":1725355646000},"page":"105237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antidementia and Psychotropic Drug Use in Older People with Dementia in Australia: A National Data Linkage Study"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5712-2337","authenticated-orcid":false,"given":"Edward C.Y.","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-8837","authenticated-orcid":false,"given":"Edwin C.K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105237_bib1","series-title":"Dementia in Australia","year":"2023"},{"key":"10.1016\/j.jamda.2024.105237_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5694\/mja2.51838","article-title":"Different estimates of the prevalence of dementia in Australia, 2021","volume":"218","author":"Dobson","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.jamda.2024.105237_bib3","first-page":"33","article-title":"Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data","volume":"46","author":"Clague","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105237_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.31128\/AJGP-05-18-4586","article-title":"Current approaches to the pharmacological treatment of Alzheimer\u2019s disease","volume":"47","author":"Tan","year":"2018","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.jamda.2024.105237_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1756285617712979","article-title":"Best practice in the management of behavioural and psychological symptoms of dementia","volume":"10","author":"Tible","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jamda.2024.105237_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2020.8519","article-title":"Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US","volume":"324","author":"Maust","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105237_bib7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.euroneuro.2018.04.005","article-title":"Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease","volume":"28","author":"Orsel","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2024.105237_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2020.01168","article-title":"Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress","volume":"11","author":"Magierski","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jamda.2024.105237_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jamda.2022.01.083","article-title":"Prevalence and risk factors for drug-related problems in people with dementia living in the community: a systematic review and meta-analysis","volume":"23","author":"Lau","year":"2022","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2024.105237_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116538","article-title":"SveDem, the Swedish Dementia Registry\u2013a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice","volume":"10","author":"Religa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2024.105237_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ageing\/afq090","article-title":"The burden of psychotropic drug prescribing in people with dementia: a population database study","volume":"39","author":"Guthrie","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105237_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89646-x","article-title":"Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care users","volume":"11","author":"Cations","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jamda.2024.105237_bib13","first-page":"3389","article-title":"Ten-year trends in psychotropic prescribing and polypharmacy in Australian general practice patients with and without dementia","volume":"12","author":"Bezabhe","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jamda.2024.105237_bib14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1017\/S1041610217002447","article-title":"A\u00a0cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern","volume":"30","author":"McMaster","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2024.105237_bib15","series-title":"Microdata: Multi-Agency Data Integration Project, MADIP; 2023","year":"2023"},{"key":"10.1016\/j.jamda.2024.105237_bib16","series-title":"2021 Census and Pharmaceutical Benefits Scheme (PBS), ABS DataLab. Findings based on use of MADIP data","year":"2021"},{"key":"10.1016\/j.jamda.2024.105237_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-015-1616-8","article-title":"The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers","volume":"8","author":"Mellish","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jamda.2024.105237_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40801-015-0036-3","article-title":"Polypharmacy among the elderly in a list-patient system","volume":"2","author":"Kann","year":"2015","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jamda.2024.105237_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2024.105237_bib21","first-page":"707","article-title":"Psychotropic polypharmacy in patients with dementia: prevalence and predictors","volume":"56","author":"N\u00f8rgaard","year":"2017","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.jamda.2024.105237_bib22","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A\u00a0test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jamda.2024.105237_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1081\/QEN-120001878","article-title":"Model-dependent variance inflation factor cutoff values","volume":"14","author":"Craney","year":"2002","journal-title":"Qual Eng"},{"issue":"5","key":"10.1016\/j.jamda.2024.105237_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the B onferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jamda.2024.105237_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0000000000000032","article-title":"Antidementia drug use among community-dwelling individuals with Alzheimer\u2019s disease in Finland: a nationwide register-based study","volume":"29","author":"Taipale","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2024.105237_bib26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jgs.14226","article-title":"Treatment patterns with antidementia drugs in the United States: medicare cohort study","volume":"64","author":"Koller","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105237_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0269881116680924","article-title":"Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology","volume":"31","author":"O\u2019Brien","year":"2017","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jamda.2024.105237_bib29","series-title":"Coordination of health care: experiences of barriers to accessing health services among patients aged 45 and over","first-page":"46","year":"2020"},{"key":"10.1016\/j.jamda.2024.105237_bib30","first-page":"398","article-title":"Aducanumab: appropriate use recommendations","volume":"8","author":"Cummings","year":"2021","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.jamda.2024.105237_bib31","volume":"1","year":"2019"},{"key":"10.1016\/j.jamda.2024.105237_bib32","article-title":"Antidepressants for treating depression in dementia","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2024.105237_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-190787","article-title":"The use of opioids and antipsychotics in elderly with dementia\u2013have opioids replaced antipsychotics in treating behavioral symptoms in dementia?","volume":"73","author":"Jensen-Dahm","year":"2020","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2024.105237_bib34","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1097\/PR9.0000000000000803","article-title":"Pain in dementia","volume":"5","author":"Achterberg","year":"2020","journal-title":"Pain Rep"},{"key":"10.1016\/j.jamda.2024.105237_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/10810730.2013.825668","article-title":"The relationship between health, education, and health literacy: results from the dutch adult literacy and life skills survey","volume":"18","author":"Van Der Heide","year":"2013","journal-title":"J\u00a0Health Commun"},{"key":"10.1016\/j.jamda.2024.105237_bib36","doi-asserted-by":"crossref","first-page":"e183750","DOI":"10.1001\/jamanetworkopen.2018.3750","article-title":"Association of focused medication review with optimization of psychotropic drug prescribing: a systematic review and meta-analysis","volume":"1","author":"Sheehan","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2024.105237_bib37","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/13607863.2021.1922601","article-title":"Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: an overview of reviews","volume":"26","author":"Wiggin","year":"2022","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2024.105237_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.socscimed.2018.02.010","article-title":"Shaping the use of psychotropic medicines in nursing homes: a qualitative study on organisational culture","volume":"202","author":"Sawan","year":"2018","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jamda.2024.105237_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-020-01741-2","article-title":"The protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) Registry","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2024.105237_bib40","series-title":"Report on the quality of 2021 Census data","author":"Harding","year":"2022"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024006595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861024006595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:43:17Z","timestamp":1730940197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861024006595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525861024006595"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105237","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidementia and Psychotropic Drug Use in Older People with Dementia in Australia: A National Data Linkage Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105237"}}